Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Duffau

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Hemasphere|February 27, 2023
Impact of Mutational Status and Prognostic Factors on Survival in Chronic Myelomonocytic Leukemia With Systemic Inflammation and Autoimmune DisordersCharles Dussiau, Henry Dupuy, Audrey Bidet, et al.
Leukemia & Lymphoma|September 3, 2021
Looking for somatic mutations in <i>UBA1</i> in patients with chronic myelomonocytic leukemia associated with systemic inflammation and autoimmune diseasesHenry Dupuy, Charles Dussiau, Audrey Bidet, et al.
Neurology|May 15, 2025
Factors Associated With Relapse in Patients With NeurosarcoidosisLouisa Nitsch, Dirk Skowasch, Edouard Courtin, et al.
Journal of Clinical Immunology|October 16, 2025
Stool Screening for Campylobacter Species in Hypogammaglobulinemic Patients Receiving Immunoglobulin TherapyBasile Mechernene, Philippe Lehours, Etienne Rivière, et al.
Nature Communications|October 31, 2024
Inflammasome-targeted therapy might prevent adverse perinatal outcomes of recurrent chronic intervillositis of unknown etiologyAurélien Mattuizzi, Fanny Sauvestre, Tiphaine Fargeix, et al.
Plos One|December 1, 2017
Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patientsAlexandre Guilhem, Anne-Emmanuelle Fargeton, Anne-Claire Simon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosisAmanda A Watkins, Kei Yasuda, Gabriella E Wilson, et al.
JCI Insight|December 21, 2018
OX40L/OX40 axis impairs follicular and natural Treg function in human SLEClément Jacquemin, Jean-François Augusto, Marc Scherlinger, et al.
Thrombosis Research|July 12, 2023
Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)Vincent Grobost, Sami Hammi, Bruno Pereira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic SclerosisMarie-Elise Truchetet, Béatrice Demoures, Jorge Eduardo Guimaraes, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Hemasphere|February 27, 2023
Impact of Mutational Status and Prognostic Factors on Survival in Chronic Myelomonocytic Leukemia With Systemic Inflammation and Autoimmune DisordersCharles Dussiau, Henry Dupuy, Audrey Bidet, et al.
Leukemia & Lymphoma|September 3, 2021
Looking for somatic mutations in <i>UBA1</i> in patients with chronic myelomonocytic leukemia associated with systemic inflammation and autoimmune diseasesHenry Dupuy, Charles Dussiau, Audrey Bidet, et al.
Neurology|May 15, 2025
Factors Associated With Relapse in Patients With NeurosarcoidosisLouisa Nitsch, Dirk Skowasch, Edouard Courtin, et al.
Journal of Clinical Immunology|October 16, 2025
Stool Screening for Campylobacter Species in Hypogammaglobulinemic Patients Receiving Immunoglobulin TherapyBasile Mechernene, Philippe Lehours, Etienne Rivière, et al.
Nature Communications|October 31, 2024
Inflammasome-targeted therapy might prevent adverse perinatal outcomes of recurrent chronic intervillositis of unknown etiologyAurélien Mattuizzi, Fanny Sauvestre, Tiphaine Fargeix, et al.
Plos One|December 1, 2017
Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patientsAlexandre Guilhem, Anne-Emmanuelle Fargeton, Anne-Claire Simon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosisAmanda A Watkins, Kei Yasuda, Gabriella E Wilson, et al.
JCI Insight|December 21, 2018
OX40L/OX40 axis impairs follicular and natural Treg function in human SLEClément Jacquemin, Jean-François Augusto, Marc Scherlinger, et al.
Thrombosis Research|July 12, 2023
Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)Vincent Grobost, Sami Hammi, Bruno Pereira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic SclerosisMarie-Elise Truchetet, Béatrice Demoures, Jorge Eduardo Guimaraes, et al.
Pageof 12